Chase AIPricingFAQs
Display currency
Loading news…

Egret Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
New York, United States Founded 2019 1-10 employees For Profit

Egret Therapeutics is a clinical-stage biotherapeutics company.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
1

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
26
IT spend
$59K

Company Info

Founded
2019
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
4
HQ
New York, United States
Region
Greater New York Area, East Coast, Northeastern US

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
-0.2
Trend (90d)
-0.6
Last leadership hire
Jul 14, 2025

Key People at Egret Therapeutics

Co-Founder & Chief Medical Officer
Chief Executive Officer
Chief Regulatory Officer
Chief Clinical Development Officer
Co-Founder
Chief of Staff
Chief Financial Officer
1
professional contacts at Egret Therapeutics
Contact execs at Egret Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Egret Therapeutics

Loading news…

FAQs about Egret Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
Egret Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments